CG Bio’s CG Medtech Holding Falls to 8,758,890 Shares After Share Consolidation

CG Bio’s CG Medtech common shares fell from 43,794,450 to 8,758,890 through a share consolidation on Oct. 7, 2026. Its ownership stake remained unchanged at 42.41% as of Oct. 15, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Medtech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015000305), on October 15, 2026, and is solely responsible for the information contained therein. (C)